A citation-based method for searching scientific literature

Beatriz Ballester, Javier Milara, Julio Cortijo. Int J Mol Sci 2019
Times Cited: 50







List of co-cited articles
190 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Lung cancer in patients with idiopathic pulmonary fibrosis.
Theodoros Karampitsakos, Vasilios Tzilas, Rodoula Tringidou, Paschalis Steiropoulos, Vasilis Aidinis, Spyros A Papiris, Demosthenes Bouros, Argyris Tzouvelekis. Pulm Pharmacol Ther 2017
61
18

The impact of lung cancer on survival of idiopathic pulmonary fibrosis.
Sara Tomassetti, Christian Gurioli, Jay H Ryu, Paul A Decker, Claudia Ravaglia, Paola Tantalocco, Matteo Buccioli, Sara Piciucchi, Nicola Sverzellati, Alessandra Dubini,[...]. Chest 2015
150
16

Cumulative incidence of and predictive factors for lung cancer in IPF.
Yuichi Ozawa, Takafumi Suda, Tateaki Naito, Noriyuki Enomoto, Dai Hashimoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hirotoshi Nakamura, Kingo Chida. Respirology 2009
158
14



Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
996
14

Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
R Hubbard, A Venn, S Lewis, J Britton. Am J Respir Crit Care Med 2000
418
14

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
12

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
12


Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis.
Eisuke Kato, Noboru Takayanagi, Yotaro Takaku, Naho Kagiyama, Tetsu Kanauchi, Takashi Ishiguro, Yutaka Sugita. ERJ Open Res 2018
28
21

Lung cancer in patients with idiopathic pulmonary fibrosis.
J Park, D S Kim, T S Shim, C M Lim, Y Koh, S D Lee, W S Kim, W D Kim, J S Lee, K S Song. Eur Respir J 2001
163
12

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF.
Paul F Mercer, Hannah V Woodcock, Jessica D Eley, Manuela Platé, Michal G Sulikowski, Pascal F Durrenberger, Linda Franklin, Carmel B Nanthakumar, Yim Man, Federica Genovese,[...]. Thorax 2016
94
10

Patients with IPF and lung cancer: diagnosis and management.
Argyris Tzouvelekis, Paolo Spagnolo, Francesco Bonella, Carlo Vancheri, Vasilios Tzilas, Bruno Crestani, Michael Kreuter, Demosthenes Bouros. Lancet Respir Med 2018
32
15


Idiopathic Pulmonary Fibrosis (IPF): An Overview.
Shaney L Barratt, Andrew Creamer, Conal Hayton, Nazia Chaudhuri. J Clin Med 2018
79
10

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
912
10

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
382
10

Global methylation patterns in idiopathic pulmonary fibrosis.
Einat I Rabinovich, Maria G Kapetanaki, Israel Steinfeld, Kevin F Gibson, Kusum V Pandit, Guoying Yu, Zohar Yakhini, Naftali Kaminski. PLoS One 2012
125
8

PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis.
Yan Geng, Xue Liu, Jiurong Liang, David M Habiel, Vrishika Kulur, Ana Lucia Coelho, Nan Deng, Ting Xie, Yizhou Wang, Ningshan Liu,[...]. JCI Insight 2019
32
12

PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production.
Lindsay J Celada, Jonathan A Kropski, Jose D Herazo-Maya, Weifeng Luo, Amy Creecy, Andrew T Abad, Ozioma S Chioma, Grace Lee, Natalie E Hassell, Guzel I Shaginurova,[...]. Sci Transl Med 2018
74
8

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
8

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
8

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
8


Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update.
Katerina M Antoniou, Sara Tomassetti, Eliza Tsitoura, Carlo Vancheri. Curr Opin Pulm Med 2015
48
8

Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.
Joo Heung Yoon, Mehdi Nouraie, Xiaoping Chen, Richard H Zou, Jacobo Sellares, Kristen L Veraldi, Jared Chiarchiaro, Kathleen Lindell, David O Wilson, Naftali Kaminski,[...]. Respir Res 2018
17
23

High-resolution computed tomography findings of lung cancer associated with idiopathic pulmonary fibrosis.
Kazuma Kishi, Sakae Homma, Atsuko Kurosaki, Noriko Motoi, Kunihiko Yoshimura. J Comput Assist Tomogr 2006
46
8

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
427
8

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Martin Reck, Rolf Kaiser, Anders Mellemgaard, Jean-Yves Douillard, Sergey Orlov, Maciej Krzakowski, Joachim von Pawel, Maya Gottfried, Igor Bondarenko, Meilin Liao,[...]. Lancet Oncol 2014
538
8

The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK.
Ivan Le Jeune, Jonathan Gribbin, Joe West, Chris Smith, Paul Cullinan, Richard Hubbard. Respir Med 2007
181
8


How strong is the association between IPF and lung cancer? An answer from airway's DNA.
G E Carpagnano, D Lacedonia, P Soccio, I Caccavo, G Patricelli, M P Foschino Barbaro. Med Oncol 2016
9
33

Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study.
Dragana Jovanovic, Marina Roksandic Milenkovic, Jelena Kotur Stevuljevic, Jelena Markovic, Vesna Ceriman, Milica Kontic, Vesna Skodric Trifunovic. J Thorac Dis 2018
17
17

Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses.
Alice Guyard, Claire Danel, Nathalie Théou-Anton, Marie-Pierre Debray, Laure Gibault, Pierre Mordant, Yves Castier, Bruno Crestani, Gérard Zalcman, Hélène Blons,[...]. Respir Res 2017
19
15

PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition.
Enrico Conte, Elisa Gili, Mary Fruciano, Martina Korfei, Evelina Fagone, Maria Iemmolo, Debora Lo Furno, Rosario Giuffrida, Nunzio Crimi, Andreas Guenther,[...]. Lab Invest 2013
50
6

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.
Toby M Maher, Eunice Oballa, Juliet K Simpson, Joanne Porte, Anthony Habgood, William A Fahy, Aiden Flynn, Philip L Molyneaux, Rebecca Braybrooke, Hrushikesh Divyateja,[...]. Lancet Respir Med 2017
82
6

Genomic profiles of lung cancer associated with idiopathic pulmonary fibrosis.
Ji An Hwang, Deokhoon Kim, Sung-Min Chun, SooHyun Bae, Joon Seon Song, Mi Young Kim, Hyun Jung Koo, Jin Woo Song, Woo Sung Kim, Jae Cheol Lee,[...]. J Pathol 2018
17
17

The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis.
Friedrich Grimminger, Andreas Günther, Carlo Vancheri. Eur Respir J 2015
70
6

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.
Takekazu Iwata, Shigetoshi Yoshida, Taiki Fujiwara, Hironobu Wada, Takahiro Nakajima, Hidemi Suzuki, Ichiro Yoshino. Ann Thorac Surg 2016
43
6

Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.
Na Xie, Zheng Tan, Sami Banerjee, Huachun Cui, Jing Ge, Rui-Ming Liu, Karen Bernard, Victor J Thannickal, Gang Liu. Am J Respir Crit Care Med 2015
165
6

Telomerase mutations in families with idiopathic pulmonary fibrosis.
Mary Y Armanios, Julian J-L Chen, Joy D Cogan, Jonathan K Alder, Roxann G Ingersoll, Cheryl Markin, William E Lawson, Mingyi Xie, Irma Vulto, John A Phillips,[...]. N Engl J Med 2007
791
6

Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.
Kohei Otsubo, Junji Kishimoto, Hirotsugu Kenmotsu, Yuji Minegishi, Eiki Ichihara, Akira Shiraki, Terufumi Kato, Shinji Atagi, Hidehito Horinouchi, Masahiko Ando,[...]. Clin Lung Cancer 2018
23
13

The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts.
Melanie Mediavilla-Varela, Kingsley Boateng, David Noyes, Scott J Antonia. BMC Cancer 2016
49
6

Idiopathic pulmonary fibrosis will increase the risk of lung cancer.
Junyao Li, Ming Yang, Ping Li, Zhenzhong Su, Peng Gao, Jie Zhang. Chin Med J (Engl) 2014
19
15

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
413
6

Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer.
Argyris Tzouvelekis, Georgia Gomatou, Evangelos Bouros, Rodoula Trigidou, Vasilios Tzilas, Demosthenes Bouros. Chest 2019
22
13

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
314
6

PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice.
Ke Ni, Ming Liu, Jian Zheng, Liyan Wen, Qingyun Chen, Zheng Xiang, Kowk-Tai Lam, Yinping Liu, Godfrey Chi-Fung Chan, Yu-Lung Lau,[...]. Am J Respir Cell Mol Biol 2018
31
9

The pathogenesis of idiopathic pulmonary fibrosis.
William R Coward, Gauri Saini, Gisli Jenkins. Ther Adv Respir Dis 2010
175
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.